Genentech
Venture capital · South San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
2Deep-tech portfolio0 active
2Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Passage Bio
20Co-investorsShare a portfolio company
Portfolio · 2 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Passage Bio | Biotech | Public | Sep 6, 2019 | $110.0M |
| Blueprint Medicines | Biotech | Acquired | Nov 20, 2014 | $73.2M |
Peer ranks
Portfolio size#189
Portfolio exits#103
Raises, 12 months#88
Co-investors#105
Co-investors
- Third Rock VenturesVenture capital2 shared
- Ascent Biomedical VenturesVenture capital1 shared
- Atlas VentureVenture capital1 shared
- BioAdvanceVenture capital1 shared
- Biotechnology Value FundVenture capital1 shared
- Boxer CapitalVenture capital1 shared
- Deerfield Capital ManagementVenture capital1 shared
- Frazier Healthcare PartnersVenture capital1 shared
- GenzymeVenture capital1 shared
- Gurnet Point CapitalVenture capital1 shared
Sectors
- Biotech2
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.